4th Quarter - Report

HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug and Medical Device Pedigree, H.R. 5839; DMEPOS and Lab Competitive Bidding, H.R. 6331; Physician Payments Sunshine Act, S. 2029

LobbyistCovered position, as disclosed
AARON FRAZIER Manager
ADNAN JALIL Director
AMY MICHAEL KOHL Senior Manager
MATTHEW JAMES ROWAN President and CEO
ANDREW VAN OSTRAND Vice President

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 2029 (110th), H.R. 5839 (110th), H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.